Meta-analysis of sirolimus for cutaneous squamous cell carcinoma in kidney transplant recipients
Sirolimus lowers skin cancer risk in kidney transplant patients
This meta-analysis of four randomized trials in kidney transplant recipients with prior cutaneous squamous cell carcinoma found that switchi…
A review of studies shows switching to sirolimus can cut skin cancer rates, but it may cause more side effects.
Guideline narrative review discusses diabetes risks from immunosuppressive therapy in kidney transplant recipients
Guidelines address diabetes risks in kidney transplant patients
This publication is a narrative review guideline addressing Post-transplant diabetes mellitus and Type 2 Diabetes.
New guidance outlines considerations for kidney transplant patients dealing with diabetes and medication risks associated with therapy.
Cohort study links ROS-high status to improved prognosis and mTOR sensitivity in stomach adenocarcinoma
New Score Predicts Better Survival in Stomach Cancer
This retrospective cohort study evaluated stomach adenocarcinoma patients using TCGA-STAD and ACRG Cohort data.
A new measurement tool can spot stomach cancer patients who have a hidden weakness that doctors can target with specific drugs.